The website of the Clinical Services Journal

Use of biosimilar medicines for IBD could save millions

A new report, published by the Royal College of Physicians on behalf of the IBD audit programme,into the use of biological therapies to treat inflammatory bowel disease (IBD), has found that new biosimilar medicines, which work in the same way as the more expensive existing treatments, are safe and effective for patients and, if adopted, can halve the cost of treatment.

The audit is the first to include data on new Infliximab ‘biosimilar’ drugs Inflectra and Remsima, now being used on patients as alternatives to the original Remicade in the treatment of IBD. These drugs are designed to have active properties similar to the biological treatment already licensed.

The report finds that biological therapies, which have revolutionised the treatment of IBD, are safe and are increasingly used on patients in the UK. It recommends the adoption of Infliximab biosimilars, as the data indicates they work as well as the original therapies and are far more cost effective to provide. Their use can reduce the cost of treatment from approximately £10,000 per patient per year to less than £5,000.

The audit, which was focused only on patients starting treatment with biologics, found that a fifth of patients are currently receiving Infliximab biosimilars and, if the therapy was extended to all patients in the audit, it would equate to an annual saving to the NHS of £3 million. 

 

 

Upcoming Events

Central Sterilising Club - Annual Scientific Meeting 2024

Crowne Plaza at Gerrard’s Cross
15th April 2024 – 16th April 2024

DECON UK 2024

National Conference Centre, Birmingham
17th April 2024

Infection Prevention & Control

National Conference Centre, Birmingham
23rd - 24th April 2024

Theatres & Decontamination Conference 2024

Coventry Building Society Arena
16th May 2024

The AfPP Roadshow - Birmingham

Millennium Point, Birmingham
18th May 2024

The AfPP Roadshow - Exeter

University of Exeter
22nd June 2024

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Upcoming Events

Central Sterilising Club - Annual Scientific Meeting 2024

Crowne Plaza at Gerrard’s Cross
15th April 2024 – 16th April 2024

DECON UK 2024

National Conference Centre, Birmingham
17th April 2024

Infection Prevention & Control

National Conference Centre, Birmingham
23rd - 24th April 2024

Theatres & Decontamination Conference 2024

Coventry Building Society Arena
16th May 2024

The AfPP Roadshow - Birmingham

Millennium Point, Birmingham
18th May 2024

The AfPP Roadshow - Exeter

University of Exeter
22nd June 2024

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025